These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [New biomarkers in prostate cancer]. Gao W; Teng LH Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):487-90. PubMed ID: 24246875 [No Abstract] [Full Text] [Related]
25. Immunotherapy for prostate cancer. Fong L; Small EJ Semin Oncol; 2003 Oct; 30(5):649-58. PubMed ID: 14571412 [TBL] [Abstract][Full Text] [Related]
26. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407 [TBL] [Abstract][Full Text] [Related]
27. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma. Chang SS; Reuter VE; Heston WD; Gaudin PB Urology; 2001 Jun; 57(6):1179-83. PubMed ID: 11377343 [TBL] [Abstract][Full Text] [Related]
28. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen. Huang X; Bennett M; Thorpe PE Prostate; 2004 Sep; 61(1):1-11. PubMed ID: 15287089 [TBL] [Abstract][Full Text] [Related]
29. Cellular distribution and heterogeneity of Psa and Psma expression in normal, hyperplasia and human prostate cancer. Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Horchani A; Oueslati R Tunis Med; 2013 Jul; 91(7):458-63. PubMed ID: 24008878 [TBL] [Abstract][Full Text] [Related]
30. [Correlation study of expression levels of prostate-specific membrane antigen and prostate-specific antigen with Gleason score of prostate carcinoma]. Ren JQ; Chen ZQ; Zheng L; Chen Q; Li H; Zhu HG Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):735-8. PubMed ID: 15733392 [TBL] [Abstract][Full Text] [Related]
31. In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen. Li Y; Tian Z; Rizvi SM; Bander NH; Allen BJ Prostate Cancer Prostatic Dis; 2002; 5(1):36-46. PubMed ID: 15195129 [TBL] [Abstract][Full Text] [Related]
33. A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation. Chiu D; Tavaré R; Haber L; Aina OH; Vazzana K; Ram P; Danton M; Finney J; Jalal S; Krueger P; Giurleo JT; Ma D; Smith E; Thurston G; Kirshner JR; Crawford A Cancer Immunol Res; 2020 May; 8(5):596-608. PubMed ID: 32184296 [TBL] [Abstract][Full Text] [Related]
34. Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen. Evans MJ; Smith-Jones PM; Wongvipat J; Navarro V; Kim S; Bander NH; Larson SM; Sawyers CL Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9578-82. PubMed ID: 21606347 [TBL] [Abstract][Full Text] [Related]
35. Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer. Barrio M; Fendler WP; Czernin J; Herrmann K Expert Rev Mol Diagn; 2016 Nov; 16(11):1177-1188. PubMed ID: 27679869 [TBL] [Abstract][Full Text] [Related]
36. The utility of PSMA and PSA immunohistochemistry in the cytologic diagnosis of metastatic prostate carcinoma. Bernacki KD; Fields KL; Roh MH Diagn Cytopathol; 2014 Jul; 42(7):570-5. PubMed ID: 24273068 [TBL] [Abstract][Full Text] [Related]
37. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate. Lv Q; Yang J; Zhang R; Yang Z; Yang Z; Wang Y; Xu Y; He Z Mol Pharm; 2018 May; 15(5):1842-1852. PubMed ID: 29608845 [TBL] [Abstract][Full Text] [Related]
38. Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system. Arndt C; Feldmann A; Koristka S; Cartellieri M; Dimmel M; Ehninger A; Ehninger G; Bachmann M Prostate; 2014 Sep; 74(13):1335-46. PubMed ID: 25053443 [TBL] [Abstract][Full Text] [Related]
39. Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers. Gong MC; Chang SS; Sadelain M; Bander NH; Heston WD Cancer Metastasis Rev; 1999; 18(4):483-90. PubMed ID: 10855791 [TBL] [Abstract][Full Text] [Related]